Anti-TNF therapy in patients with HBV infection-analysis of 87 patients with inflammatory arthritis

Clinical Rheumatology

Volumn 33, Issue 1, 2014, Pages 119-123

  Ye, Hua ^a   Zhang, Xue Wu ^a   Mu, Rong ^a   Fang, Lin Kai ^b   Gu, Jie Ruo ^b   Lin, Jin ^c   Du, Jin Feng ^d   Chen, Jin Wei ^d   Chen, Yi Jia ^e   Wu, Li Jun ^e   Pang, Xue Feng ^f   Li, Zhan Guo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e Xinjiang Autonomous Region People Hospital   (China)

^f GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Etanercept; Hepatitis bvirus; Infliximab; Tumor necrosis factor inhibitors

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ETANERCEPT; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; INFLIXIMAB; LAMIVUDINE; TUMOR NECROSIS FACTOR INHIBITOR; VIRUS DNA;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK REDUCTION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD; YOUNG ADULT;

EID: 84900356261     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2385-1     Document Type: Article

References (13)

1. LeeWM(1997) Hepatitis B virus infection.N Engl J Med 337:1733-1745
2. Liang XF, Chen YS, Wang XJ et al (2005) A study on the seroepidemiology of hepatitis B in Chinese population aged over 3-years old. Chin J Epidemiol 26:655-658
3. Tan J, Zhou J, Zhao P et al (2012) Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs. Clin Rheumatol 31:1169-1175
4. MokMY, NgWL, YuenMF et al (2000) Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. Clin Exp Rheumatol 18:363-368
5. Zingarelli S, Frassi M, Bazzani C et al (2009) Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: report of 3 cases and review of the literature. J Rheumatol 36: 1188-1194
6. Lan JL, Chen YM, Hsieh TYet al (2011) Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibodypositive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy. Ann Rheum Dis 70:1719-1725
7. Vassilopoulos D, Apostolopoulou A, Hadziyannis E et al (2010) Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection. Ann Rheum Dis 69:1352-1355
8. Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45: 507-539
9. Kawanishi Y, Hayashi N, Katayama K et al (1995) Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells. J Med Virol 47:272-277
10. Ostuni P, Botsios C, Punzi L et al (2003) Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 62:686-687
11. Pérez-Alvarez R, Díaz-Lagares C, García- Hernández F et al (2011) Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases. Medicine (Baltimore) 90:359-371
12. Stine JG, Khokhar OS, Charalambopoulos J et al (2010) Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy. Arthritis Care Res (Hoboken) 62:704-711
13. Lee YH, Bae SC, Song GG (2013) Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy. Clin Exp Rheumatol 31:118-121